207 results match your criteria: "Nagasaki-Genbaku Hospital[Affiliation]"

Utility values of responders and nonresponders are essential inputs in cost-effectiveness studies of radiation therapy for painful bone metastases but, to our knowledge, they have not been reported separately. We sought to determine the utility values of responders and nonresponders using data from a prospective observational study on bone metastases. The original prospective observational study was conducted at 26 centers in Japan.

View Article and Find Full Text PDF

Luspatercept has shown durable clinical efficacy for the treatment of anemia in transfusion-dependent patients with lower-risk myelodysplastic syndromes (LR-MDS). We report the results of a prespecified primary analysis of a phase 2 trial of luspatercept in non-transfusion-dependent (NTD) Japanese patients with anemia due to LR-MDS. Luspatercept (starting dose 1.

View Article and Find Full Text PDF

Relapsing peritoneal dialysis-associated peritonitis caused by Corynebacterium striatum: a case report.

CEN Case Rep

November 2024

Department of Nephrology Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.

Peritoneal dialysis (PD)-associated peritonitis is a serious complication of PD, and its prevention and treatment are important for reducing patient morbidity and mortality. Reports of PD-associated peritonitis caused by Corynebacterium spp. are limited, and PD-associated peritonitis caused by Corynebacterium striatum (C.

View Article and Find Full Text PDF

Introduction: Fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) improve overall survival (OS) and progression-free survival (PFS) in patients with pancreatic cancer, compared with gemcitabine (GEM). However, whether PFS is a surrogate marker of OS in pancreatic cancer chemotherapy focusing on FOLFIRINOX or GEM plus nab-paclitaxel remains unknown. We aimed to verify whether PFS can be a surrogate marker of OS in prognosis prediction.

View Article and Find Full Text PDF
Article Synopsis
  • A 63-year-old man with relapsed acute myeloid leukemia underwent a third stem cell transplant and was given voriconazole to prevent fungal infections.
  • On day 42 post-transplant, he developed septic arthritis without the typical skin signs associated with fungal infections.
  • Despite surgery and treatment with liposomal amphotericin B, he died due to a resistant fungal infection, highlighting the need to consider azole-resistant infections as potential causes of septic arthritis in similar patients.
View Article and Find Full Text PDF

Feasibility of a problem-solving exercise program based on short physical performance battery for older patients with chronic respiratory diseases: A multicenter, pilot clinical trial.

Respir Investig

November 2024

Department of Rehabilitation Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, Japan; Department of Physical Therapy Science, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, Japan.

Article Synopsis
  • The study evaluated the feasibility and safety of a problem-solving exercise program for older patients with chronic respiratory diseases, focusing on balance, walking, and chair stands.
  • With 36 participants, the program showed high adherence (100%) and no related adverse events, with significant improvements in daily step count and physical performance scores over four weeks.
  • While results indicate that the exercise program is both feasible and safe, further validation in larger randomized controlled trials is necessary to confirm its effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • A clinical pathway was implemented in Nagasaki hospitals for managing LDL cholesterol (LDL-C) after acute myocardial infarction (AMI) to improve patient outcomes.
  • The study found that the percentage of patients achieving the LDL-C target of <70 mg/dL increased from 37.2% to 54.6% after the pathway was introduced.
  • Overall, the implementation of this pathway significantly enhanced lipid-lowering therapy effectiveness in hospitals performing percutaneous coronary interventions (PCI).
View Article and Find Full Text PDF

Background And Aims: The impact of hepatitis C virus (HCV) eradication via direct-acting antiviral (DAA) therapy on overall mortality, particularly non-liver-related mortality, is understudied.

Methods: We recruited 4180 patients with chronic HCV infection who achieved sustained virological response (SVR) (HCV eradication) through DAA therapy (n = 2501, SVR group) or who did not receive antiviral therapy (n = 1679, non-SVR group); 1236 from each group were chosen using propensity score matching. Causes of death and all-cause mortality, including non-liver-related diseases, were investigated.

View Article and Find Full Text PDF

Background: Endoscopic submucosal dissection (ESD) is a potentially efficient therapeutic intervention for superficial esophageal cancer. Additional treatment such as chemoradiotherapy (CRT) or esophagectomy is recommended in cases of muscularis mucosa invasion with positive resection margins or lymphovascular invasion or submucosal layer invasion, which are considered noncurative ESD, due to an increased risk of lymph node metastasis. However, the adequacy of additional CRT after near-circumferential or full-circumferential noncurative ESD has not been fully discussed.

View Article and Find Full Text PDF
Article Synopsis
  • - This study compared the effectiveness of second-line treatments for patients with unresectable pancreatic cancer who previously received gemcitabine plus nab-paclitaxel (GnP), analyzing 318 patients treated with nanoliposomal irinotecan plus 5-fluorouracil/folinic acid (NFF), S-1, or FOLFIRINOX.
  • - Results showed that the median overall survival (OS) for the NFF group was significantly better at 9.08 months compared to 4.90 months for S-1, while FOLFIRINOX had an OS of 4.77 months with no significant difference from NFF.
  • - Factors like serum levels and duration
View Article and Find Full Text PDF

Purpose Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect of antiresorptive agents such as bisphosphonates (BPs) and denosumab (DMB). We investigated whether a difference exists between BP- and DMB-related osteonecrosis of the jaw (ONJ). Patients and methods Histological images of 30 patients with BP-related ONJ and 13 patients with DMB-related ONJ were observed using hematoxylin-eosin and cathepsin K staining.

View Article and Find Full Text PDF

Background /purpose: The standard treatment for medication-related osteonecrosis of the jaw (MRONJ) is surgery. However, reports on the appropriate extent of bone resection are few. We aimed to examine the relationship between the extent of bone resection and postoperative outcomes in patients with mandibular MRONJ.

View Article and Find Full Text PDF

Background: NY-ESO-1 and XAGE1 cancer/testis antigens elicit humoral and cellular immune responses in NSCLC patients. We aimed to predict clinical benefit with ICI monotherapy, using an automated immunoassay of NY-ESO-1/XAGE1 antibodies (Abs).

Methods: This study enrolled 99 NSCLC patients who received nivolumab after chemotherapy, including 21 patients harboring EGFR, ALK, or KRAS alterations.

View Article and Find Full Text PDF
Article Synopsis
  • After pancreaticoduodenectomy, 20-40% of patients experience steatotic liver disease (SLD), but the role of specific gene polymorphisms (PNPLA3 and TM6SF2) in this condition post-surgery is not well understood.
  • A study involving 43 pancreatic cancer patients assessed these gene variants and their correlation with SLD and high hepatic fibrosis indexes (HFI) after surgery.
  • Results indicated that while PNPLA3 variants showed no significant association, the TM6SF2 minor allele was linked to a higher incidence of steatohepatitis, suggesting its potential impact on liver health after the procedure.*
View Article and Find Full Text PDF

Nanoliposomal irinotecan with fluorouracil and folinic acid (NFF) is a standard regimen after gemcitabine-based therapy for patients with unresectable or recurrent pancreatic cancer. However, there are limited clinical data on its efficacy and safety in the real-world. We therefore initiated a retrospective and prospective observational study (NAPOLEON-2).

View Article and Find Full Text PDF

Background And Objective: The identification of factors associated with long-term prognosis after community-onset pneumonia in elderly patients should be considered when initiating advance care planning (ACP). We aimed to identify these factors and develop a prediction score model.

Methods: Patients aged 65 years and older, who were hospitalized for pneumonia at nine collaborating institutions, were included.

View Article and Find Full Text PDF

Objective: To examine the effect of isometric quadriceps exercises with visual and auditory feedback after total knee arthroplasty (TKA).

Methods: The sample included 41 patients from our previous study who could be followed up for 1 year after TKA. Patients in the intervention group performed isometric quadriceps exercises with visual and auditory feedback using the quadriceps training machine from the 2nd to the 14th day after TKA, whereas those in the control group underwent standard postoperative rehabilitation (without visual or auditory feedback during isometric quadriceps exercises) in the hospital.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effectiveness of 8-week vs. 12-week glecaprevir and pibrentasvir (GLE/PIB) treatment for chronic hepatitis C, focusing on both non-cirrhotic and cirrhotic patients in Japan.
  • The study enrolled 1,275 patients and primarily measured the sustained virological response (SVR) rates for different treatment durations and liver conditions.
  • Results showed high SVR rates (98.9% to 100%) across all groups, indicating that both 8-week and 12-week treatment regimens are effective regardless of liver fibrosis status.
View Article and Find Full Text PDF

Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept.

Life (Basel)

April 2024

Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Sakamoto 1-7-1, Nagasaki 852-8102, Japan.

Article Synopsis
  • - The study examined why some patients with type 1 macular neovascularization (MNV) successfully switched to faricimab after being unresponsive to intravitreal aflibercept (IVA).
  • - Out of 43 patients analyzed, 32.6% experienced an extension of their treatment intervals by more than two weeks after switching to faricimab.
  • - Factors contributing to successful treatment extension included shorter dosing intervals prior to switching, the absence of polypoidal lesions, and thinner central choroidal thickness.
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes mortality rates in patients who achieved sustained virological response (SVR) after receiving interferon-free direct-acting antiviral (IFN-free DAA) therapy, emphasizing the significance of non-liver-related deaths.
  • Three cohorts were examined: those without advanced fibrosis or prior hepatocellular carcinoma (HCC), those with advanced fibrosis but no prior HCC, and those with a history of HCC after curative treatment.
  • Findings indicated that while both non-HCC cohorts had comparable mortality rates to the general population, the cohort with a history of HCC had higher overall mortality, highlighting the need to address non-liver-related health issues in all SVR patients.
View Article and Find Full Text PDF
Article Synopsis
  • * A study of 126 Japanese patients using wKd therapy showed an overall response rate of 66.3% and a median progression-free survival of 9.5 months.
  • * The study also reported that treatment-emergent adverse events occurred in 45.8% of patients, with 20.8% experiencing severe (grade ≥3) events, but no new safety concerns were identified.
View Article and Find Full Text PDF

Organized hematoma of the sphenoid sinus with epistaxis.

Radiol Case Rep

March 2024

Department of Otolaryngology-Head and Neck Surgery, The Japanese Red Cross Nagasaki Genbaku Hospital, 3-15 Morimachi, Nagasaki 852-8511, Japan.

Few reports have been made on organized hematoma (OH) originating in the sphenoid sinus. We report the case of a 24-year-old man who presented to the hospital with consistent epistaxis for 1 month. Preoperative computed tomography and magnetic resonance imaging (MRI) detected an expansive heterogeneous mass with minimal bone destruction and hypointense peripheral rim in T2-weighted images of the left sphenoid sinus as a solitary lesion.

View Article and Find Full Text PDF

Background: For chronic pain after thoracic surgery, optimal timing of its diagnosis and effective treatment remains unresolved, although several treatment options are currently available. We examined the efficacy and safety of mirogabalin, in combination with conventional pain therapy (nonsteroidal anti-inflammatory drugs and/or acetaminophen), for treating peripheral neuropathic pain (NeP) after thoracic surgery.

Methods: In this multicenter, randomized, open-label, parallel-group study, patients with peripheral NeP were randomly assigned 1:1 to mirogabalin as add-on to conventional therapy or conventional treatment alone.

View Article and Find Full Text PDF

Background: Nursing- and healthcare-associated pneumonia (NHCAP) constitutes most of the pneumonia in elderly patients including aspiration pneumonia in Japan. Lascufloxacin (LSFX) possesses broad antibacterial activity against respiratory pathogens, such as Streptococcus spp. And anaerobes inside the oral cavity.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on rare renal cell carcinomas (RCCs) that show features similar to haemangioblastomas, with a specific look at their clinicopathological characteristics and VHL gene alterations, comparing them to clear cell renal cell carcinomas (CCRCCs) that also exhibit these features.
  • - The identified RCCs with haemangioblastoma-like features are generally indolent, have a distinct appearance with a thick capsule, and specific immunohistochemical profiles, but do not show typical VHL mutations, indicating a different molecular behavior.
  • - Findings suggest these RCCs can be differentiated from CCRCCs, as they exhibit unique features in terms of blood vessel and cell structure, as well as differences in genetic mutations
View Article and Find Full Text PDF